# OnCo record jan-vermorken (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jan-vermorken/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jan-vermorken" ;
  schema:name "Jan B. Vermorken"@en ;
  schema:description "Led EXTREME and TAX 323, which defined the chemotherapy standards for head and neck cancer for a decade."@en ;
  schema:url <https://onco.cc/people/jan-vermorken/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Vermorken%20JB%5BAuthor%5D%20head%20neck%20cetuximab> ;
  onco:tag "head-and-neck", "chemotherapy", "eortc" ;
  schema:jobTitle "Emeritus Professor of Oncology, Antwerp University Hospital" ;
  schema:sameAs <https://orcid.org/0000-0001-8515-7848> ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/platinum/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:institutions <https://onco.cc/institutions/antwerp-university-hospital/> ;
  onco:trials <https://onco.cc/trials/extreme/> ;
  schema:affiliation <https://onco.cc/institutions/antwerp-university-hospital/> .